Moreover, NFκB signaling was activated primarily by stimuli including IL1 signaling, contributing to the development of skin problems in Sharpincpdm mice, and NFκB inhibitor, bortezomib, showed better therapy effect for dermatitis and mouse survival. The gene discussed is IL1B; the disease is skin disorder.